Avantor launches new single-use bioproduction plant in the Netherlands

NETHERLANDS – Avantor, Inc., a global provider of products and services to the life sciences, advanced technologies, and applied materials industries, has announced the opening of a new single-use facility in Hillegom, Netherlands.

The facility is Avantor’s second single-use location in Europe, following its Tilburg, Netherlands location, and adds significantly to the company’s overall cleanroom capacity in the region, serving regional and global customers.

The Hillegom facility, located in the Dutch industrial corridor between Amsterdam and Leiden, enables Avantor to manufacture, package, and deliver single-use solutions that support all stages of biologics manufacturing, including upstream, downstream, and fill-finish.

Avantor, a Fortune 500 company, is a global leader in providing mission-critical products and services to customers in the biopharma.

Avantor, in addition to its biopharmaceutical capabilities, provides advanced healthcare materials such as high-purity silicones, proven diagnostic solutions, and nutraceutical products to a wide range of healthcare needs.

Its diagnostic solutions include reagents and analytical systems for applications such as histology, hematology and immunology.

Moreover, it also provides clinical diagnostic systems used to collect, transport, and test biological specimens, thus helping to improve the quality and affordability of diagnostic tools.

Its global presence allows it to serve over 225,000 customer locations and provides it with extensive access to research laboratories and scientists in over 180 countries, setting Science in motion to make the world a better place.

We continue to grow our single-use footprint and capabilities to serve the needs of the global biopharma industry,” said Dr. Ger Brophy, Executive Vice President of Biopharma Production at Avantor.

We are proud to be part of the Hillegom community and boost our presence in the Netherlands. Opening this site also reflects our commitment to support the growing demand for speed and efficiency in bioproduction. This facility will enhance the regional single-use supply chain in Europe, and Avantor looks forward to continuing to grow our business in this important market.”

Avantor’s global single-use footprint also includes multiple sites in the United States, as well as a site in Changzhou, China, acquired as part of the Company’s recent acquisition of RIM Bio.

In addition, Avantor recently announced its intention to acquire Masterflex, a leading global manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies, which will expand its offering across all bioproduction platforms.

Would you like to get regular updates of such news articles? Subscribe to our HealthCare Africa News, email newsletters, which provide the latest news insights from Africa and the World’s health, pharma and biotech industry. SUBSCRIBE HERE

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.